Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 26;9(1):9291.
doi: 10.1038/s41598-019-45743-6.

Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKIIδ oxidation

Affiliations

Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKIIδ oxidation

Yuejin Wu et al. Sci Rep. .

Abstract

Reactive oxygen species (ROS) contribute to myocardial death during ischemia-reperfusion (I/R) injury, but detailed knowledge of molecular pathways connecting ROS to cardiac injury is lacking. Activation of the Ca2+/calmodulin-dependent protein kinase II (CaMKIIδ) is implicated in myocardial death, and CaMKII can be activated by ROS (ox-CaMKII) through oxidation of regulatory domain methionines (Met281/282). We examined I/R injury in mice where CaMKIIδ was made resistant to ROS activation by knock-in replacement of regulatory domain methionines with valines (MMVV). We found reduced myocardial death, and improved left ventricular function 24 hours after I/R injury in MMVV in vivo and in vitro compared to WT controls. Loss of ATP sensitive K+ channel (KATP) current contributes to I/R injury, and CaMKII promotes sequestration of KATP from myocardial cell membranes. KATP current density was significantly reduced by H2O2 in WT ventricular myocytes, but not in MMVV, showing ox-CaMKII decreases KATP availability. Taken together, these findings support a view that ox-CaMKII and KATP are components of a signaling axis promoting I/R injury by ROS.

PubMed Disclaimer

Conflict of interest statement

M.E. Anderson is a cofounder of Allosteros Therapeutics, a biotech company developing CaMKII inhibitor drugs to treat cardiovascular disease.

Figures

Figure 1
Figure 1
MMVV mice are protected against I/R injury. (A) Representative images of transverse cardiac sections from WT (left) and MMVV (right) mice after I/R surgery. Area at risk (AAR) is the sum of red and white areas, and the area of necrosis (AON) is white. The blue area is outside of the AAR. (B) Summary data for AON/AAR. The AON/AAR was significantly reduced in MMVV hearts (n = 7) compared to their littermate WT hearts (n = 6). *p < 0.05 unpaired Student’s t-test. (C) Summary data for AAR measured over the left ventricle (LV). (D) LV ejection fractions (E) LV fractional shortening (F) LVID-S (LV internal diameter in systole) before and after I/R surgery in MMVV (n = 22) and WT (n = 21) mice. One way ANOVA (P < 0.0001). Tukey’s multiple comparisons test compared each group, as indicated by brackets *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. (G) Representative images of ventricular myocytes isolated from MMVV (right) and littermate WT (left) hearts under I/R control conditions with all experimental steps except addition of an oil layer (−oil, upper) and simulated cellular I/R (+oil, lower). Scale bar is 100 µm. (H) Summary data for cell viability expressed as the percentage of live cells. Each point was a summary of 7–10 fields of cell counting (~50–100 cells in each field). Cells from 9 WT mice and 10 MMVV mice. One way ANOVA (P < 0.0001). Tukey’s multiple comparisons test compared each group, as indicated by brackets *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. (I) Representative images of ventricular myocytes isolated from MMVV (right) and littermate WT (left) hearts under control conditions (−H2O2, upper) and after addition of 1 mM H2O2 (+H2O2, lower). The scale bar is 100 µm. (J) Summary data for cell viability based on percentage of live cells, under different concentrations of H2O2. Cells are from 2 mice from each group. Data were analyzed with a one way ANOVA test (P < 0.0001). Sidak’s multiple comparisons test was used for comparisons between groups. All comparisons between the 1 mM H2O2 and other groups were significant (P < 0.0001). Significantly more MMVV compared to WT ventricular myocytes were viable after 1 mM H2O2 (*p < 0.05).
Figure 2
Figure 2
MMVV ventricular myocytes are resistant to H2O2-induced reduction in IKATP. (A) Representative traces of IKATP in response to a ramp command pulse (inset) from ventricular myocytes isolated from WT and MMVV mice in the presence of pinacidil and DNP with (black line) and without (red line) H2O2. Glibenclamide was added to eliminate IKATP (blue line). Inset schematics indicate patch clamp configurations used to obtain each data set, here and throughout. (B) IKATP recorded at 0 mV, with and without H2O2, from ventricular myocytes isolated from WT (n = 11 cells, 2 mice) and MMVV (n = 13 cells, 3 mice) mice. (C) Representative traces of KATP channel currents recorded from ventricular myocytes in cell attached mode in the presence of the DNP with and without H2O2. The vertical scale bar 5 pA, and the horizontal scale bar 2 s (same scale for panel F and I). (D) Number of KATP channels opening in each membrane patch under conditions with and without H2O2. (E) KATP channel open probability (NPo) calculated from the membrane patches analyzed in (D). WT (6–13 cells, 2 mice), MMVV (6 cells, 2 mice). (F) Representative traces of KATP channel recording from excised cell membrane patches in inside-out mode at −60 mV membrane potential and H2O2 treatment, ATP, and after washout. (G) Number of KATP channels opening in each membrane patch under conditions with and without H2O2. (H) KATP NPo calculated from the membrane patches analyzed in (G), 5–6 cells from 3 WT mice and 12 cells from 3 MMVV mice. (I) Representative KATP channel currents recorded from WT isolated ventricular myocytes in cell attached mode in the presence of DNP with and without H2O2. The lower panel shows cells pretreated with Dynasore. (J) Number of KATP channels opening in each membrane patch under conditions with and without H2O2 and with and without pretreatment of Dynasore. (K) KATP NPo calculated from the membrane patches analyzed in (J), 5–12 cells in each group, 3 WT mice. One way ANOVA and Tukey’s multiple comparisons test were used for comparing each group in all the bar graph panels,*p < 0.05, **p < 0.01, ***p < 0.001.
Figure 3
Figure 3
Normal exercise capacity, glucose tolerance, and glucose-induced insulin secretion, but reduced and H2O2-resistant IKATP in CaMKII resistant KIR 6.2 T224A mice. (A) Sanger sequencing results of PCR products amplified from genomic DNA of wildtype (WT/WT), heterozygous (WT/T224A) and homozygous mutant mice (T224A/T224A). (B) DNA gel electrophoresis of PCR products before and after NheI digestion. (C) WT and T224A mice were fasted for 16 hours (overnight) and then injected intraperitoneally with 2 g/kg glucose to assess glucose tolerance. No significant difference was found between the WT and T224A mice. (D) Area under the curve (AUC) of the measurements in (C). (E) Serum insulin concentrations were not significantly different between WT and T224A mice either after 16-hour fasting or 15 minutes after 2 g/kg glucose injection. (F) No difference between genotypes in blood glucose concentrations measured during glucose‐induced insulin secretion. (G) Representative IKATP currents recorded from ventricular myocytes isolated from WT and T224A mice using the same protocol and conditions as shown in Fig. 2A. (H) IKATP recorded at 0 mV, with and without H2O2, from ventricular myocytes isolated from WT (n = 9–13 cells, 3 mice) and T224A (n = 8 cells, 3 mice) mice. One way ANOVA and Tukey’s multiple comparisons test were used for comparisons between groups as marked by brackets (*p < 0.05, **p < 0.01). (I) Representative traces of KATP channel currents recorded from isolated ventricular myocytes in cell attached mode in the presence of the KATP channel opener DNP with and without H2O2. The vertical scale bar 5 pA, and the horizontal scale bar 2 s. (J) Number of KATP channel openings in each membrane patch under conditions with and without H2O2, as in Fig. 2D. One way ANOVA and Tukey’s multiple comparisons test were used for intergroup comparisons (*p < 0.05, **p < 0.01). (K) Summary data of open probability (NPo) in KATP channels analyzed from cell membrane patches shown in (J). One way ANOVA was used for comparison between all groups (P > 0.05). WT (4–7 cells, 2 mice), T224A (13–23 cells, 4 mice). (L) Expression of Kir6.2 in the heart was measured by RT-qPCR (Normalized against Gapdh, n = 5 for each genotype).
Figure 4
Figure 4
Ox-CaMKII resistant MMVV and pinacidil provide non-additive protection against I/R injury in isolated ventricular myocytes. (AD) Summary data for cell viability in ventricular myocytes isolated from WT littermates of MMVV mice (A, cells from 3–9 mice/group), MMVV mice (B, cells from 4–10 mice/group), WT littermate of T224A mice (C, cells from 3 WT mice) and T224A mice (D, cells from 4 T224A mice) under control conditions (−oil) without drug treatment (left bar), with pinacidil 10 µM (middle bar), or with glibenclamide 2 µM (right bar). One way ANOVA was used for statistical analysis; Tukey’s multiple comparisons test was used for intergroup comparisons (*p < 0.05, ***p < 0.001, ****p < 0.0001). (EH) Summary data for viability of ventricular myocytes isolated from WT littermate of MMVV mice (E, cells from 3–9 mice/group), MMVV mice (F, cells from 4–10 mice/group), WT littermates of T224A mice (G, cells from 3 WT mice) and T224A mice (H, cells from 4 T224A mice) under simulated I/R condition (+oil) without drug treatment (left bar), with pinacidil 10 µM (middle bar), or with glibenclamide 2 µM (right bar). One way ANOVA was used for statistical analysis; Tukey’s multiple comparisons test was used for intergroup comparisons (**p < 0.01, ***p < 0.001, ****p < 0.0001).
Figure 5
Figure 5
The proposed pathway for ox-CaMKII causing increased myocardial death after I/R injury by enhancing sequestration of KATP channels. I/R injury leads to reduced ATP and increased ROS. Reduced ATP increases KATP opening to protect cardiomyocytes, but ROS oxidize CaMKII, and ox-CaMKII enhances KATP endocytosis leading to reduced IKATP and increased myocardial death. Mice lacking ox-CaMKIIδ (MMVV) are relatively protected from loss of IKATP and myocardial death after I/R. Dynasore, an endocytosis blocker added to WT ventricular myocytes, and ventricular myocytes isolated from MMVV mice show similar protection against loss of IKATP.

Similar articles

Cited by

References

    1. Nabel EG, Braunwald EA. Tale of coronary artery disease and myocardial infarction. N. Engl. J. Med. 2012;366:54–63. doi: 10.1056/NEJMra1112570. - DOI - PubMed
    1. Ibáñez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J. Am. Coll. Cardiol. 2015;65:1454–1471. doi: 10.1016/j.jacc.2015.02.032. - DOI - PubMed
    1. Fuster V. Top 10 cardiovascular therapies and interventions for the next decade. Nat. Rev. Cardiol. 2014;11:671–683. doi: 10.1038/nrcardio.2014.137. - DOI - PubMed
    1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N. Engl. J. Med. 2007;357:1121–35. doi: 10.1056/NEJMra071667. - DOI - PubMed
    1. Chouchani ET, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431–435. doi: 10.1038/nature13909. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources